Papillion Research Center/CCT Research

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	Ear Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Photophobia, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, eye disorder, headache disorder, hearing disorder, hyperacusis, hypnic headache, migraine disorder, nervous system disorder, otorhinolaryngologic disease, vision disorder	Recruiting	Phase 3	2026-09-28		NCT05156398
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine	Alphavirus infectious disease, Encephalitis, Arbovirus, Encephalitis, Viral, Encephalomyelitis, Equine, Infections, Mosquito-Borne Diseases, Neuroinflammatory Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, encephalomyelitis, infectious encephalitis, nervous system disorder, vector-borne disease, viral infection of central nervous system, viral infectious disease	Active, not recruiting	Phase 2	2025-10-01		NCT06899802

Clinical trials